These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 36812043)
1. Patient-Reported Financial Toxicity in a Population-Based Cohort of Oropharynx Cancer Survivors. Diao K; Lei X; Smith GL; Jagsi R; Peterson SE; Sumer BD; Smith BD; Sher DJ Int J Radiat Oncol Biol Phys; 2023 May; 116(1):142-153. PubMed ID: 36812043 [TBL] [Abstract][Full Text] [Related]
2. Long-term Patient-Reported Outcomes in a Population-Based Cohort Following Radiotherapy vs Surgery for Oropharyngeal Cancer. Dohopolski MJ; Diao K; Hutcheson KA; Akhave NS; Goepfert RP; He W; Lei XJ; Peterson SK; Shen Y; Sumer BD; Smith BD; Sher DJ JAMA Otolaryngol Head Neck Surg; 2023 Aug; 149(8):697-707. PubMed ID: 37382943 [TBL] [Abstract][Full Text] [Related]
3. Risk and Clinical Risk Factors Associated With Late Lower Cranial Neuropathy in Long-term Oropharyngeal Squamous Cell Carcinoma Survivors. Aggarwal P; Goepfert RP; Garden AS; Garg N; Zaveri JS; Du XL; Swartz MD; Lai SY; Fuller CD; Ferrarotto R; Sturgis EM; Piller LB; Hutcheson KA JAMA Otolaryngol Head Neck Surg; 2021 May; 147(5):469-478. PubMed ID: 33538759 [TBL] [Abstract][Full Text] [Related]
4. Association of Risk Factors With Patient-Reported Voice and Speech Symptoms Among Long-term Survivors of Oropharyngeal Cancer. Aggarwal P; Hutcheson KA; Garden AS; Mott FE; Goepfert RP; Duvall A; Fuller CD; Lai SY; Gunn GB; Sturgis EM; Hanna EY; Shete S JAMA Otolaryngol Head Neck Surg; 2021 Jul; 147(7):615-623. PubMed ID: 33956062 [TBL] [Abstract][Full Text] [Related]
5. Understanding financial toxicity in head and neck cancer survivors. Mady LJ; Lyu L; Owoc MS; Peddada SD; Thomas TH; Sabik LM; Johnson JT; Nilsen ML Oral Oncol; 2019 Aug; 95():187-193. PubMed ID: 31345389 [TBL] [Abstract][Full Text] [Related]
6. Symptom Burden Associated With Late Lower Cranial Neuropathy in Long-term Oropharyngeal Cancer Survivors. Aggarwal P; Zaveri JS; Goepfert RP; Shi Q; Du XL; Swartz M; Gunn GB; Lai SY; Fuller CD; Hanna EY; Rosenthal DI; Lewin JS; Piller LB; Hutcheson KA JAMA Otolaryngol Head Neck Surg; 2018 Nov; 144(11):1066-1076. PubMed ID: 30193299 [TBL] [Abstract][Full Text] [Related]
7. Disparities in survival outcomes among Black patients with HPV-associated oropharyngeal cancer. Baliga S; Mitchell D; Yildiz VO; Gogineni E; Konieczkowski DJ; Grecula J; Blakaj DM; Liu X; Gamez ME J Med Virol; 2023 Feb; 95(2):e28448. PubMed ID: 36583477 [TBL] [Abstract][Full Text] [Related]
8. Females Have Worse Overall and Disease-Specific Survival in Human Papillomavirus-Negative Oropharyngeal Squamous Cell Carcinoma. Hunter WP; Harris JA; Lee CC; Cheng AC; Peacock ZS J Oral Maxillofac Surg; 2022 Jul; 80(7):1260-1271. PubMed ID: 35469827 [TBL] [Abstract][Full Text] [Related]
9. Patient-reported financial toxicity and adverse medical consequences in head and neck cancer. Beeler WH; Bellile EL; Casper KA; Jaworski E; Burger NJ; Malloy KM; Spector ME; Shuman AG; Rosko A; Stucken CL; Chinn SB; Dragovic AF; Chapman CH; Owen D; Jolly S; Bradford CR; Prince MEP; Worden FP; Jagsi R; Mierzwa ML; Swiecicki PL Oral Oncol; 2020 Feb; 101():104521. PubMed ID: 31877502 [TBL] [Abstract][Full Text] [Related]
10. Patient-reported outcomes of symptom burden in patients receiving surgical or nonsurgical treatment for low-intermediate risk oropharyngeal squamous cell carcinoma: A comparative analysis of a prospective registry. Amit M; Hutcheson K; Zaveri J; Lewin J; Kupferman ME; Hessel AC; Goepfert RP; Brandon Gunn G; Garden AS; Ferraratto R; Dave Fuller C; Tam S; Gross ND Oral Oncol; 2019 Apr; 91():13-20. PubMed ID: 30926057 [TBL] [Abstract][Full Text] [Related]
11. Financial Toxicity and Its Association With Health-Related Quality of Life Among Partners of Colorectal Cancer Survivors. Ghazal LV; Abrahamse P; Ward KC; Morris AM; Hawley ST; Veenstra CM JAMA Netw Open; 2023 Apr; 6(4):e235897. PubMed ID: 37022684 [TBL] [Abstract][Full Text] [Related]
12. Radiation Therapy Alone for Human Papillomavirus-Related Squamous Cell Carcinoma of the Oropharynx: A Single-Arm, Phase 2 Study. Takemoto N; Seo Y; Nakahara S; Yoshioka Y; Teshima T; Fujii T; Isohashi F; Otani K; Yoshii T; Takenaka Y; Suzuki M; Fukusumi T; Hanamoto A; Yasui T; Michiba T; Yamamoto Y; Shimamoto S; Tanaka H; Tatsumi M; Ogawa K; Inohara H Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):403-411. PubMed ID: 33373656 [TBL] [Abstract][Full Text] [Related]
13. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer. Fakhry C; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig E; Yin LX; Ryan WR; Ha PK; Wentz A; Koch W; Richmon JD; Eisele DW; D'Souza G Cancer; 2017 May; 123(9):1566-1575. PubMed ID: 28241096 [TBL] [Abstract][Full Text] [Related]
14. Measuring financial toxicity in head and neck cancer: a systematic review. Raggini E; Mattavelli D; Zigliani G; Bossi P; Piazza C Acta Otorhinolaryngol Ital; 2024 Feb; 44(1):1-12. PubMed ID: 38420716 [TBL] [Abstract][Full Text] [Related]
15. The invisible scars: Unseen financial complications worsen every aspect of long-term health in trauma survivors. Ilkhani S; Naus AE; Pinkes N; Rafaqat W; Grobman B; Valverde MD; Sanchez SE; Hwabejire JO; Ranganathan K; Scott JW; Herrera-Escobar JP; Salim A; Anderson GA J Trauma Acute Care Surg; 2024 Jun; 96(6):893-900. PubMed ID: 38227675 [TBL] [Abstract][Full Text] [Related]
16. Symptom burden and dysphagia associated with osteoradionecrosis in long-term oropharynx cancer survivors: A cohort analysis. Wong ATT; Lai SY; Gunn GB; Beadle BM; Fuller CD; Barrow MP; Hofstede TM; Chambers MS; Sturgis EM; Mohamed ASR; Lewin JS; Hutcheson KA Oral Oncol; 2017 Mar; 66():75-80. PubMed ID: 28249651 [TBL] [Abstract][Full Text] [Related]
17. Primary transoral robotic surgery with concurrent neck dissection for early stage oropharyngeal squamous cell carcinoma implemented at a Danish head and neck cancer center: a phase II trial on feasibility and tumour margin status. Rubek N; Channir HI; Charabi BW; Lajer CB; Kiss K; Nielsen HU; Bentzen J; Friborg J; von Buchwald C Eur Arch Otorhinolaryngol; 2017 May; 274(5):2229-2237. PubMed ID: 28050651 [TBL] [Abstract][Full Text] [Related]
18. Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients ≥65 years old. ; Eraj SA; Jomaa MK; Rock CD; Mohamed ASR; Smith BD; Smith JB; Browne T; Cooksey LC; Williams B; Temple B; Preston KE; Aymard JM; Gross ND; Weber RS; Hessel AC; Ferrarotto R; Phan J; Sturgis EM; Hanna EY; Frank SJ; Morrison WH; Goepfert RP; Lai SY; Rosenthal DI; Mendoza TR; Cleeland CS; Hutcheson KA; Fuller CD; Garden AS; Gunn GB Radiat Oncol; 2017 Sep; 12(1):150. PubMed ID: 28888224 [TBL] [Abstract][Full Text] [Related]
19. Assessing the Prevalence of Financial Toxicity, its Predictors and Association with Health- Related Quality of Life Among Radiation Oncology Patients in India: A Cross-Sectional Patient Reported Outcome Study. Dar MA; Chauhan R; Trivedi V; Kumar R; Dhingra S Int J Radiat Oncol Biol Phys; 2023 May; 116(1):157-165. PubMed ID: 36455689 [TBL] [Abstract][Full Text] [Related]
20. Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR Trial. Nichols AC; Theurer J; Prisman E; Read N; Berthelet E; Tran E; Fung K; de Almeida JR; Bayley A; Goldstein DP; Hier M; Sultanem K; Richardson K; Mlynarek A; Krishnan S; Le H; Yoo J; MacNeil SD; Winquist E; Hammond JA; Venkatesan V; Kuruvilla S; Warner A; Mitchell S; Chen J; Corsten M; Johnson-Obaseki S; Odell M; Parker C; Wehrli B; Kwan K; Palma DA J Clin Oncol; 2022 Mar; 40(8):866-875. PubMed ID: 34995124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]